WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · HB 600

Legislative bill overview

HB 600 relates to the medical use of cannabis in Hawaii, though the bill text itself is not provided in your submission. Based on the legislative timeline, this measure was introduced in the 2025 session, referred to multiple committees (Health, Consumer Protection, and Finance), and ultimately deferred and carried over to the 2026 session without passage.

Why is this important

Medical cannabis policy directly affects patients seeking alternative treatments, healthcare providers' prescribing practices, and state regulatory frameworks. Hawaii's approach to medical cannabis influences patient access, product safety standards, and the interaction between state law and federal restrictions on cannabis.

Potential points of contention

  • Scope of medical conditions: Disagreement over which medical conditions qualify patients for medical cannabis access
  • Regulatory oversight: Questions about which state agencies oversee licensing, product testing, and patient protections
  • Implementation costs: Concerns about state funding required for regulatory infrastructure and program administration

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.